Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04946370
Title Maximizing Responses to Anti-PD1 Immunotherapy With PSMA-targeted Alpha Therapy in mCRPC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

prostate adenocarcinoma

castration-resistant prostate carcinoma

Therapies

Pembrolizumab

225Ac-J591 + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.